Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8733121 | Health Policy and Technology | 2018 | 31 Pages |
Abstract
The generic drug market in Turkey has not reached its full potential. Original pharmaceuticals still dominate most of the market. The internal reference pricing system in Turkey has not been able to encourage price competitiveness and price reductions.
Related Topics
Health Sciences
Medicine and Dentistry
Health Informatics
Authors
Seda Kumru, Mehmet Top,